Google Translate:
Dr. Brotzu
New Alopecia Cure: A Drug Coming In 2016 To Cure Alopecia Discovered by Dr. Brotzu
Physicians and clinical treatment pathways for the treatment of alopecia have, in recent years, real strides and different doctors have taken real experiments to try to intervene in a disease for which to date no treatment outcome certainly positive, alopecia. It is a genetic autoimmune disease, non-infectious, which affects on average 2% of the world population, irrespective of age, sex or skin color but also by food and personal habits. Its course, given the fact that manifests itself in different forms, can be unpredictable but involves in all cases the fall of hair or hair that may arrive, in the more serious forms, to a total loss. Alopecia is a term derived from Greek, is in fact related to the word Alopex, meaning fox, given the fact that hair loss occurs in a similar manner to the spring wetsuit fox, or patchy. In addition to the changes from the aesthetic point of view, therefore, the alopecia has consequences from the psychological point of view, causing insecurity, loss of confidence, embarrassment that can evolve into real depression.
Dr. John Brotzu
There are many factors which contribute in triggering the alopecia and it was not as yet possible to identify a single causative factor as with other diseases. The treatment of alopecia in 2015 did not lead to universally positive results although several have been taken to the streets look for if not to arrest, at least to limit the consequences related to this disease.
Among the most interesting is that of John Brotzu, born in 1934, she obtained a degree in medicine in 1958 at the University of Cagliari and a rich experience behind countless trips abroad, particularly in Sweden, France and United States , to attend graduate schools and internships but also to gain experience; son of Joseph Brotzu, discoverer of cephalosporins, a new class of antibiotics, backed by intense political activity as President of the Sardinia Region and the Mayor of Cagliari, as well as a hospital complex in Cagliari that bears his name, Nanni , he is best known as his son, the estimate of the mother. Physician, professor and researcher, is among the proponents of a new methodology for the treatment of alopecia, through a kind of preparation for the treatment of androgenetic alopecia, the results of which were published in the 'Dermatologist' magazine.
What could be the avenue for the treatment of alopecia in 2016 was born after some research on diabetes, whose first consequence is the narrowing of the capillaries known as stenosis, which does not allow red blood cells to pass, going to spray the peripheral areas of the body. Among the different consequences there is also the fall of the hairs of the legs, if the microcirculation not be quickly reactivated.
The work of Professor Brotzu team tried to inject a substance known as Phe1 intravenously within the fat molecules, allowing in this way to reach the capillary cells and reactivate them, allowing to regrow hair and to ulcers caused by stenosis to heal in a short themes. A preparation which therefore had the credentials to be used on the skin for groped to stop hair loss. The work team has used imperfect preparations, ie not used for the treatments related to diabetes, with interesting results in terms of reduction of hair loss.
In short, from an accident for the treatment of diabetic microangiopathy it has been possible to shape a possible cure of baldness. Since the first discovery has passed into the next stage, the replacement of PGE1 with the DGLA; it is an acid, the presence of which is found in many essential oils, used by Dr. Brotzu to create a spreadable lotion that can represent the great novelty for the treatment of alopecia in 2016. E 'sufficient spread it because it is absorbed from the skin by attaching to endothelial cells and transformed, through a natural chemical reaction, the active ingredient PGE1.
A stroke of genius that led to the creation of a cosmetic spreads from a drug for diabetes. In short, the preparation made by the vascular surgeon, along with his team, could therefore represent the final resolution to issues related to alopecia, common baldness (androgenetic alopecia) including but telogen effluvium and alopecia areata.
The drug for the treatment of alopecia should be put on the market by the second quarter of 2016 and can be purchased without a prescription. All thanks to several years of research by Professor Brotzu, in a successful attempt to transform a born product as a cosmetic drug.
UPDATE 01/30/2016: We published an interview with Dr. John Brotzu.
UPDATE 30/06/2016: We contacted Dr. Brotzu and FIDIA. The following updates.
When is the sale of the new drug for the treatment of alopecia?
We are receiving numerous contact email for information on the marketing of the drug described here. In the interview to Dr. Brotzu lay ahead fact a release in the first half of 2016, but obviously (and rightly) the times are longer than expected because you have to carry out extensive clinical tests (and are working on a significant sample of people) .
The professor. Brotzu in recent contact tells us that "I'm running a search in patients with alopecia and alopecia totalis while FIDIA is performing a test in Milan sull'alopecia androgenetic. I think the Fidia will market the lotion at the end of Milan test, but I do not have precise information. Ask the Fidia. Sincerely, Brotzu "
So we asked for clarification from the Fidia, the company precisely who is testing the drug and who will take care of the future sale and entry into the market. We still have no official response therefore does not publish information that would be untrue. However, they confirm when told by Dr. Brotzu, or that you are in a clinical trial of the drug and that may essereci new developments by the end of 2016.
As soon as we will post updates about them on this page. Please actively readers not to contact the editors to ask questions on the sale of the drug because we have no information or contact you want to send. Thank you for understanding.
